Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02417922
Other study ID # H-1-2010-052
Secondary ID
Status Completed
Phase N/A
First received December 8, 2011
Last updated April 15, 2015
Start date February 2011
Est. completion date November 2014

Study information

Verified date April 2015
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose is to see if Autologous Conditioned Plasma (ACP) promote and accelerating tendon tissue healing in Conservative treated total Achilles Tendon Tears.

40 healthy males were randomized to either receive ACP or Placebo (saline) around the ruptured achilles tendon at baseline, 2 weeks, 4 weeks and again after 6 weeks during the 8 weeks immobilization period with an orthosis. Ultrasound and symptoms scores (ATLS) was performed at baseline, after 8 weeks immobilization and again after 3 month, 6 month and 12 month. Scoring and functional tests was performed after the 8 weeks immobilization and again after 12 weeks, 24 weeks and 52 weeks from injury date.


Description:

Total achilles rupture is a severe injury and many has long lasting functional deficit afterwards. Treatment options is either operative or conservative treatment. Conservative treatment for total Achilles rupture has become more and more popular during the last 10 years. Nevertheless we still see a higher risk of re-rupture compared to surgery.

Aim: The aim of the study is in patients with acute total Achilles tendon rupture to examine if Autologous Conditioned Plasma (ACP) promote and accelerate tendon tissue healing in Conservative treated total Achilles tendon rupture and thereby gives a better functional outcome.

Materials and methods: Healthy males (25-60 years; n=40) with acute total achilles tendon ruptures is randomly assigned to either 1) ACP (~ 4 mls) or 2) placebo (saline ~ 4 mls) treatment. Participants will be treated on 4 successive occasions with 2 weeks (wks) interval during the 8 week conservative treatment with an orthoses. The injections will be performed under ultrasound guidance. All subjects will undergo a 8 weeks immobilization period with an orthoses with full weigh bearing and after that they will be guided in a proper rehabilitation regime during the intervention. Clinical effects will be assessed as changes in functional scoring system (ATLS), isometric muscle strength and muscle function (one-legged heel-rise test). Furthermore tendon length will be measured by ultrasound. All outcome measures will be recorded at baseline and again after 8 weeks immobilization (expect muscle strength and function), 12 weeks, 24 weeks and 52 weeks after injury.

Results: Look at possible changes and differences between groups (ACP and Placebo) in ATLS scores, muscle strength, ultrasound tendon length elongation and muscle function.

Statistics: All data will be analyzed in SigmaPlot v11 using two-way repeated measures ANOVA with Student-Newman-Keuls Post-hoc test. This is used to see changes over time in all groups (time effect) and differences between groups within time-points (group effect). All data will be presented as mean ± SEM time.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date November 2014
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Male
Age group 25 Years to 60 Years
Eligibility Inclusion Criteria:

- Age 25-60 years.

- The patient must be able to speak and understand Danish.

- The patient must be able to give informed consent.

- The patient should be able to follow the instructed regimen with a removable ankle orthosis.

- The patient must be able to determine when rupture occurred, and it can't be over 4 days old.

- The patient should be able to follow the postoperative controls.

Exclusion Criteria:

- Terminal illness.

- Former achilles tendon rupture

- Former surgery on the achilles tendon

- Treatment with fluoroquinolones during the last 6 months.

- Tendinosis treated with a tablet or injection with corticosteroids within the last 6 months.

- Diagnosis of arterial insufficient in the leg.

- Lack of palpable pulse in the foot

- Severe medical illness: ASA score greater than 2

Study Design

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Saline
4 mls of saline is injected 4 times around the injured tendon area every 2nd week during the 8 weeks of conservative treatment.
ACP
4 mls of ACP is injected 4 times around the injured tendon area every 2nd week during the 8 weeks of conservative treatment.

Locations

Country Name City State
Denmark Institute of Sportsmedicine, Bispebjerg hospital Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Bispebjerg Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary ATRS (Achilles Tendon Total Rupture Score) Patient-reported validated scoring tool developed for assessment of symptoms and physical activity after treatment for acute achilles tendon rupture (score 0-100 points) After immobilization period (8 weeks) and again after 12 weeks, 24 weeks and 52 weeks from injury date Yes
Secondary Isometric Strength test The subjects were asked to produce an isometric contraction of the calf muscle with increasing force to their maximum voluntary effort (MVC) over a 10 sec period. The MVC was performed on both legs to measure the differences between the two legs. After 12 weeks, 24 weeks and 52 weeks from injury date Yes
Secondary Heel-rise test The accumulated work made doing repetitive heel-rises is measured on each leg to see the differences between the two legs. After 12 weeks, 24 weeks and 52 weeks from injury date Yes
Secondary Tendon elongation Tendon length was measured with ultrasound on both legs during intervention to see possible tendon elongation after achilles rupture. The landmarks for measure the tendon length was the proximal part of the top of the calcaneus bone and most distal part of the muscular-tendinous part of the m. gastrocnemius medial. At baseline, after immobilization (8 weeks) and again after 12 weeks, 24 weeks and 52 weeks from injury date Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04976335 - Quantitative and Clinical Assessment of Flexor Tendon Gliding Following Application of a Bioresorbable Hydrogel: A Prospective, Randomized Study in Patients Undergoing Distal Radius Fracture Repair N/A
Completed NCT03823755 - Evaluation of the Mobility of the Digital Flexor Tendons
Completed NCT03747198 - Methylsulfonylmethane on Knee Laxity N/A
Recruiting NCT05371938 - Volar Locking Plate Versus External Fixation for Distal Radius Fracture - a Longterm Follow up N/A